NCT00530842 - Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD | Biotech Hunter

Enrollment

344

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2009

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium plus Salmeterol

DRUG

Fluticasone/Salmeterol

Trial Locations (42)

Unknown

205.334.4309 Boehringer Ingelheim Investigational Site, Gänserndorf

205.334.4308 Boehringer Ingelheim Investigational Site, Hallein

205.334.4306 Boehringer Ingelheim Investigational Site, Leoben

205.334.4301 Boehringer Ingelheim Investigational Site, Linz

205.334.4302 Boehringer Ingelheim Investigational Site, Neumarkt am Wallersee

205.334.4305 Boehringer Ingelheim Investigational Site, Salzburg

205.334.1009 Boehringer Ingelheim Investigational Site, Vancouver

205.334.1003 Boehringer Ingelheim Investigational Site, Halifax

205.334.1005 Boehringer Ingelheim Investigational Site, Hamilton

205.334.1008 Boehringer Ingelheim Investigational Site, Kingston

205.334.1004 Boehringer Ingelheim Investigational Site, Ottawa

205.334.1010 Boehringer Ingelheim Investigational Site, Toronto

205.334.1001 Boehringer Ingelheim Investigational Site, Montreal

205.334.1006 Boehringer Ingelheim Investigational Site, Québec

205.334.1007 Boehringer Ingelheim Investigational Site, Saskatoon

205.334.3303A Boehringer Ingelheim Investigational Site, Beuvry

205.334.3303B Boehringer Ingelheim Investigational Site, Beuvry

205.334.3305A Boehringer Ingelheim Investigational Site, Créteil

205.334.3301A Boehringer Ingelheim Investigational Site, Grenoble

205.334.3304A Boehringer Ingelheim Investigational Site, Saint-Priest-en-Jarez

205.334.3306A Boehringer Ingelheim Investigational Site, Strasbourg

205.334.3306B Boehringer Ingelheim Investigational Site, Strasbourg

205.334.3302A Boehringer Ingelheim Investigational Site, Toulouse

205.334.3302B Boehringer Ingelheim Investigational Site, Toulouse

205.334.4908 Boehringer Ingelheim Investigational Site, Berlin

205.334.4909 Boehringer Ingelheim Investigational Site, Berlin

205.334.4902 Boehringer Ingelheim Investigational Site, Cologne

205.334.4904 Boehringer Ingelheim Investigational Site, Donaustauf

205.334.4901 Boehringer Ingelheim Investigational Site, Großhansdorf

205.334.4907 Boehringer Ingelheim Investigational Site, Kiel

205.334.39007 Boehringer Ingelheim Investigational Site, Catania

205.334.39002 Boehringer Ingelheim Investigational Site, Gaiato Pavullo (mo)

205.334.39004 Boehringer Ingelheim Investigational Site, Milan

205.334.39001 Boehringer Ingelheim Investigational Site, Pisa

205.334.39005 Boehringer Ingelheim Investigational Site, Roma

205.334.39006 Boehringer Ingelheim Investigational Site, Roma

205.334.7001 Boehringer Ingelheim Investigational Site, Moscow

205.334.7002 Boehringer Ingelheim Investigational Site, Moscow

205.334.7003 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.334.46003 Boehringer Ingelheim Investigational Site, Jönköping

205.334.46002 Boehringer Ingelheim Investigational Site, Lund

205.334.46001 Boehringer Ingelheim Investigational Site, Uppsala